Johannes P D Schultheiss
4PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Aug 21, 2024
Limited predictive value of the gut microbiome and metabolome for response to biological therapy in inflammatory bowel disease.Femke M Prins, Iwan J Hidding, Marjolein A Y Klaassen
|Feb 04, 2021
Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel Disease.Shaden Mahmmod, Johannes P D Schultheiss, Ad A van Bodegraven
|Jun 20, 2020
Adherence to Adalimumab Was Not Improved by a Reminder-Based Intervention with an Electronic Needle Container.Johannes P D Schultheiss, Sandra Altena, Max R Clevers
|Jul 17, 2019
Earlier discontinuation of TNF-α inhibitor therapy in female patients with inflammatory bowel disease is related to a greater risk of side effects.Johannes P D Schultheiss, Eelco C Brand, Evert Lamers
Pageof 1
Frequent Collaborators
1 joint publications
Lisa J T Smits
1 joint publications
Femke M Prins
1 joint publications
Iwan J Hidding
1 joint publications
Valerie Collij
1 joint publications
Werna T C Uniken Venema
1 joint publications
Amber Bangma
1 joint publications
Eleonora A M Festen
1 joint publications
Gerard Dijkstra
1 joint publications
Marijn C Visschedijk
1 joint publications
Arnau Vich Vila
